Stay updated on Ixazomib & Dexamethasone in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib & Dexamethasone in Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib & Dexamethasone in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe history shows a new revision entry v3.3.2 added and the previous revision v3.3.1 removed in the Record History page.SummaryDifference0.1%

- Check33 days agoChange DetectedThe revision history now includes a new entry for v3.3.1 and removes the previous v3.2.0 from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe banner about funding and government operating status was removed; the page's core trial record content remains unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedA new version entry appears in the Record History, expanding the version list without altering core study details visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference9%

Stay in the know with updates to Ixazomib & Dexamethasone in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib & Dexamethasone in Multiple Myeloma Clinical Trial page.